Foghorn Therapeutics (FHTX) Earnings Date, Estimates & Call Transcripts $3.88 +0.07 (+1.84%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$3.88 0.00 (-0.13%) As of 03/27/2025 04:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Foghorn Therapeutics Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 5Before Market OpensEstimatedActual EPS (Mar. 6) -$0.30 Beat By $0.13 Consensus EPS (Mar. 6) -$0.43 Foghorn Therapeutics issued Q4 2024 earnings on March 6, 2025, reporting an EPS of -$0.30, which beat the consensus estimate of -$0.43 by $0.13. Quarterly revenue was reported to be $2.86 million, below analysts' expectations of $8.56 million. With a trailing EPS of -$1.65, Foghorn Therapeutics' earnings are expected to grow next year, from ($1.55) to ($1.02) per share. FHTX Upcoming EarningsFoghorn Therapeutics' next earnings date is estimated for Monday, May 5, 2025, based off prior year's reporting schedules. Get Foghorn Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Foghorn Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataFHTX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.FHTX Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Foghorn Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.34-$0.24-$0.30Q2 20253-$0.33-$0.25-$0.30Q3 20253-$0.31-$0.25-$0.29Q4 20253-$0.40-$0.26-$0.32FY 202512($1.38)($1.00)($1.21) Remove Ads Foghorn Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/5/2025(Estimated)-------3/6/2025Q4 2024-$0.43-$0.30+$0.13-$0.30$8.56M$2.86M8/8/2024--$0.60-$0.45+$0.15-$0.45$6.60M$6.89M5/6/2024Q1 2024-$0.55-$0.59 -$0.04-$0.59$7.53M$5.05M3/7/2024Q4 2023-$0.79-$0.57+$0.22-$0.57$4.91M$5.77M11/2/2023Q3 2023-$0.72-$0.34+$0.38-$0.34$6.20M$17.48M8/4/2023Q2 2023-$0.73-$0.70+$0.03-$0.70$6.65M$5.60M5/8/2023Q1 2023-$0.71-$0.73 -$0.02-$0.73$6.09M$5.31M Foghorn Therapeutics Earnings - Frequently Asked Questions When is Foghorn Therapeutics's earnings date? Foghorn Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates. Learn more on FHTX's earnings history. Did Foghorn Therapeutics beat their earnings estimates last quarter? In the previous quarter, Foghorn Therapeutics (NASDAQ:FHTX) reported ($0.30) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.43) by $0.13. Learn more on analysts' earnings estimate vs. FHTX's actual earnings. How much revenue does Foghorn Therapeutics generate each year? Foghorn Therapeutics (NASDAQ:FHTX) has a recorded annual revenue of $22.60 million. How much profit does Foghorn Therapeutics generate each year? Foghorn Therapeutics (NASDAQ:FHTX) has a recorded net income of -$98.43 million. FHTX has generated -$1.65 earnings per share over the last four quarters. What is Foghorn Therapeutics's EPS forecast for next year? Foghorn Therapeutics's earnings are expected to grow from ($1.55) per share to ($1.02) per share in the next year. More Earnings Resources from MarketBeat Related Companies Rocket Pharmaceuticals Earnings Xencor Earnings Zymeworks Earnings Xeris Biopharma Earnings Phibro Animal Health Earnings Gyre Therapeutics Earnings Oculis Earnings Replimune Group Earnings Cogent Biosciences Earnings Day One Biopharmaceuticals Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss Remove Ads This page (NASDAQ:FHTX) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Foghorn Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Foghorn Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FHTX Stock Free FHTX Stock Alerts